BCR-ABL激酶区突变在酪氨酸激酶抑制剂耐药慢性髓性白血病患者中的分布及其影响因素

OBJECTIVE: To explore BCR-ABL kinase domain mutation profiles and clinical variables associated with them in tyrosine kinase inhibitor (TKI)-resistant patients with chronic myeloid leukemia (CML). METHODS: Imatinib-, nilotinib-, and/or dasatinib-resistant patients with CML who screened BCR-ABL mutat...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Zhonghua Xue Ye Xue Za Zhi
Format: Artigo
Sprog:Inglês
Udgivet: Editorial office of Chinese Journal of Hematology 2020
Fag:
论著
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7378281/
https://ncbi.nlm.nih.gov/pubmed/32654459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.06.006
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker